Disclosed herein is a pharmaceutical composition particularly “tablet in tablet dosage form” that is characterized to act in different release profiles and behaviour and gets released at the specific site of action in a predictable manner to maximise the desired pharmacological activity.
The invention discloses a bilayered tablet composition comprising Domperidone in sustained release dosage form and Pantoprazole in conventional release dosage form for the effective treatment of gastro-intestinal symptoms related to the treatment of Parkinson's disease with dopamine agonists.
This invention relates to an effervescent pharmaceutical formulation comprising alendronate sodium for oral solution. The formulation employs fluidized bed granulation technology combined with specific excipients to enhance solubility, stability, and palatability, ensuring improved patient compliance and therapeutic...